Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The protein encoded by RECK is a cysteine-rich, extracellular protein with protease inhibitor-like domains whose expression is suppressed strongly in many tumors and cells transformed by various kinds of oncogenes. Additionally we are shipping RECK Antibodies (66) and RECK Proteins (4) and many more products for this protein.
Showing 2 out of 5 products:
the aim of this study was to analyze the effect of RECK gene rs 11788747 single nucleotide polymorphism (SNP) on hepatocellular carcinoma (HCC (show FAM126A ELISA Kits)) susceptibility.
Findings suggest that RECK transcript variants might have opposite roles in GBM biology and the ratio of their expression levels may be informative for the prognostic outcome of GBM patients.
miR (show MLXIP ELISA Kits)-21 has a role in upregulating PTEN, RECK and PDCD4 (show PDCD4 ELISA Kits) in glioma
RECK is a regulator of hMSC functions suggesting that modulation of RECK may improve the development of hMSC-based therapeutical approaches in regenerative medicine.
MMP-9 (show MMP9 ELISA Kits)/RECK imbalance in cervical smears is significantly associated with high-grade cervical diseases and infection by alpha-9 HPV and C. trachomatis.
RECK is not an independent prognostic marker for breast cancer
miR (show MLXIP ELISA Kits)-221/miR (show MLXIP ELISA Kits)-222-RECK axis might be an important path modulating H. pylori infection-related gastric cancer development
Expression of RECK is associated with the incidence of restenosis after vascular angioplasty. RECK may be induced as a part of the intrinsic defense mechanism against restenosis.
This downregulation of RECK in advanced grades of osteosarcoma and metastatic grades was also associated with the increased expression of invadosome-specific markers like MMP9 (show MMP9 ELISA Kits)
present data indicate that there is a significant association between mutant G of rs11788747 in RECK and WT risk
These findings demonstrate the importance of appropriate cell-cell interactions and ECM (show MMRN1 ELISA Kits) maintenance for angiogenesis and the involvement of Reck as a critical regulator of these events.
RECK-mediated beta1-Integrin regulation by TGF-beta1 (show TGFB1 ELISA Kits) is critical for wound contraction in mice.
MiR (show MLXIP ELISA Kits)-21 modulated the osteoporosis by targeting RECK.
microRNA-200b and microRNA-200c promote colorectal cancer cell proliferation via targeting RECK.
The RECK silencing-EGFR (show EGFR ELISA Kits)-HIF-2alpha (show EPAS1 ELISA Kits) axis might be a key molecular mechanism to induce hyperplastic phenotype of epithelial cells.
Angiotensin II suppresses RECK, but induces matrix metalloproteinases both in vivo and in vitro.
therapeutic concentrations of ASA (show ARSA ELISA Kits) inhibited IL-18 (show IL18 ELISA Kits)-induced H(2)O(2) generation, MMP9 (show MMP9 ELISA Kits) activation, RECK suppression, and CF migration.
these data suggest that RECK is a novel transcriptional target of FXR (show NR1H4 ELISA Kits) in mouse liver, and provide clues to better understanding the function of FXR (show NR1H4 ELISA Kits) in liver.
RECK expression in the mouse uterus is steroidally regulated and within endometrial epithelial and stromal cells, RECK regulates MMP9 (show MMP9 ELISA Kits), but not MMP2 (show MMP2 ELISA Kits) activity.
After treatment with NS398, RECK expression increased and MMP9 (show MMP9 ELISA Kits) expression decreased in mice with prostate cancer.
The protein encoded by this gene is a cysteine-rich, extracellular protein with protease inhibitor-like domains whose expression is suppressed strongly in many tumors and cells transformed by various kinds of oncogenes. In normal cells, this membrane-anchored glycoprotein may serve as a negative regulator for matrix metalloproteinase-9, a key enzyme involved in tumor invasion and metastasis.
membrane-anchored glycoprotein (metastasis and invasion)
, reversion-inducing cysteine-rich protein with Kazal motifs
, suppression of tumorigenicity 15 (reversion-inducing-cysteine-rich protein with kazal motifs)
, suppression of tumorigenicity 5 (reversion-inducing-cysteine-rich protein with kazal motifs)
, suppressor of tumorigenicity 15 protein
, Reversion-inducing cysteine-rich protein with Kazal motifs precursor (mRECK)
, membrane-anchored glycoprotein RECK
, suppression of tumorigenicity 15
, reversion-inducing-cysteine-rich protein with Kasal motifs